Education
About Us
Working with TipRanks
Follow Us
GenSight Biologics SA (FR:SIGHT)
:SIGHT
GenSight Biologics ($DE:G49N) announced an update on their ongoing clinical study. The REVISE study, officially titled “A Dose-ranging Randomized, Open-label Study Evaluating the Effect of Bilateral Intravitreal Injection of GS010
...Read more
SIGHT News on the Web
TipRanks News
Neutral
TipRanks News
Bullish
TipRanks News
Bearish
TipRanks News
Neutral
Simply Wall St
Bearish
TipRanks News
Neutral
Clinical Trials Arena
Neutral
TipRanks News
Neutral
News Score - Last 7 Days
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.
This score is generated using a formula that combines Media Buzz and News Sentiment.
This score is generated using a formula that combines Media Buzz and News Sentiment.
Media Coverage Analysis
The historical news coverage of this asset in the last three months.
FAQ
What is FR:SIGHT’s Media Buzz Sentiment?
Currently, no data Available
What is FR:SIGHT’s weekly average amount of articles?
Currently, no data Available
What is FR:SIGHT’s News Sentiment?
Currently, no data Available